Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.
Lyndra Therapeutics has raised $101.0M in total funding. The most recent round was Series E. The last funding was announced in December 2023.
Lyndra Therapeutics's investors include Bill & Melinda Gates Foundation, Gilead Sciences, Polaris Partners, Invus, Mass General Brigham.
Lyndra Therapeutics is headquartered in Watertown, United States.
Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.
Lyndra Therapeutics is at the Series E stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lyndra Therapeutics — Funding & Investors." VCBacked, December 21, 2023, https://www.vcbacked.co/company/lyndra-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Lyndra Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lyndra-therapeutics
{{cite web |title=Lyndra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lyndra-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated